523 related articles for article (PubMed ID: 8623206)
41. "Alternatively activated" dendritic cells preferentially secrete IL-10, expand Foxp3+CD4+ T cells, and induce long-term organ allograft survival in combination with CTLA4-Ig.
Lan YY; Wang Z; Raimondi G; Wu W; Colvin BL; de Creus A; Thomson AW
J Immunol; 2006 Nov; 177(9):5868-77. PubMed ID: 17056511
[TBL] [Abstract][Full Text] [Related]
42. Induction of immunologic tolerance to cardiac allograft by simultaneous blockade of inducible co-stimulator and cytotoxic T-lymphocyte antigen 4 pathway.
Kosuge H; Suzuki J; Gotoh R; Koga N; Ito H; Isobe M; Inobe M; Uede T
Transplantation; 2003 Apr; 75(8):1374-9. PubMed ID: 12717233
[TBL] [Abstract][Full Text] [Related]
43. [CTLA4-Ig prevents corneal allograft rejection in mice].
Shi WY; Xie LX
Zhonghua Yan Ke Za Zhi; 2004 Oct; 40(10):696-700. PubMed ID: 16200862
[TBL] [Abstract][Full Text] [Related]
44. Modulation of costimulation by CD28 and CD154 alters the kinetics and cellular characteristics of corneal allograft rejection.
Ardjomand N; McAlister JC; Rogers NJ; Tan PH; George AJ; Larkin DF
Invest Ophthalmol Vis Sci; 2003 Sep; 44(9):3899-905. PubMed ID: 12939307
[TBL] [Abstract][Full Text] [Related]
45. Treatment of allograft recipients with donor-specific transfusion and anti-CD154 antibody leads to deletion of alloreactive CD8+ T cells and prolonged graft survival in a CTLA4-dependent manner.
Iwakoshi NN; Mordes JP; Markees TG; Phillips NE; Rossini AA; Greiner DL
J Immunol; 2000 Jan; 164(1):512-21. PubMed ID: 10605049
[TBL] [Abstract][Full Text] [Related]
46. B7-dependent T-cell costimulation in mice lacking CD28 and CTLA4.
Mandelbrot DA; Oosterwegel MA; Shimizu K; Yamada A; Freeman GJ; Mitchell RN; Sayegh MH; Sharpe AH
J Clin Invest; 2001 Apr; 107(7):881-7. PubMed ID: 11285307
[TBL] [Abstract][Full Text] [Related]
47. Costimulatory blockade prevents early rejection, promotes lymphocyte apoptosis, and inhibits the upregulation of intragraft interleukin-6 in an orthotopic liver transplant model in the rat.
Bartlett AS; McCall JL; Ameratunga R; Howden B; Yeong ML; Benjamin CD; Hess D; Peach R; Munn SR
Liver Transpl; 2002 May; 8(5):458-68. PubMed ID: 12004346
[TBL] [Abstract][Full Text] [Related]
48. [Immunomodulation after keratoplasty by CTL4-Ig and anti-CD154 antibodies].
Zhang EP; Bulfone-Paus S; Hoffmann F
Ophthalmologe; 2002 Mar; 99(3):183-7. PubMed ID: 11917801
[TBL] [Abstract][Full Text] [Related]
49. The role of CD80, CD86, and CTLA4 in alloimmune responses and the induction of long-term allograft survival.
Judge TA; Wu Z; Zheng XG; Sharpe AH; Sayegh MH; Turka LA
J Immunol; 1999 Feb; 162(4):1947-51. PubMed ID: 9973463
[TBL] [Abstract][Full Text] [Related]
50. Improved survival of biolistically transfected mouse islet allografts expressing CTLA4-Ig or soluble Fas ligand.
Gainer AL; Suarez-Pinzon WL; Min WP; Swiston JR; Hancock-Friesen C; Korbutt GS; Rajotte RV; Warnock GL; Elliott JF
Transplantation; 1998 Jul; 66(2):194-9. PubMed ID: 9701263
[TBL] [Abstract][Full Text] [Related]
51. Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion.
Lin H; Bolling SF; Linsley PS; Wei RQ; Gordon D; Thompson CB; Turka LA
J Exp Med; 1993 Nov; 178(5):1801-6. PubMed ID: 8228826
[TBL] [Abstract][Full Text] [Related]
52. A short course of tofacitinib sustains the immunoregulatory effect of CTLA4-Ig in the presence of inflammatory cytokines and promotes long-term survival of murine cardiac allografts.
Iglesias M; Khalifian S; Oh BC; Zhang Y; Miller D; Beck S; Brandacher G; Raimondi G
Am J Transplant; 2021 Aug; 21(8):2675-2687. PubMed ID: 33331121
[TBL] [Abstract][Full Text] [Related]
53. CD28 blockade alters cytokine mRNA profiles in cardiac transplantation.
Lin H; Wei RQ; Goodman RE; Bolling SF
Surgery; 1997 Aug; 122(2):129-37. PubMed ID: 9288115
[TBL] [Abstract][Full Text] [Related]
54. Treatment with CTLA4-Ig inhibits rejection of liver allografts from FIt3-ligand-treated donors.
Fu F; Li W; Lu L; Fung JJ; Thomson AW; Qian S
Transplant Proc; 1999; 31(1-2):453. PubMed ID: 10083185
[No Abstract] [Full Text] [Related]
55. IL-2 pathway blocking in combination with anti-CD154 synergistically establishes mixed macrochimerism with limited dose of bone marrow cells and prolongs skin graft survival in mice.
Lee JH; Ha J; Kim SH; Kim SJ
J Korean Med Sci; 2006 Dec; 21(6):1005-11. PubMed ID: 17179677
[TBL] [Abstract][Full Text] [Related]
56. Locally expressed CTLA4-Ig in a pancreatic beta-cell line suppresses accelerated graft rejection response induced by donor-specific transfusion.
Kimura F; Gotoh M; Tanaka T; Luo Z; Miyazaki J; Uede T; Monden M; Miyasaka M
Diabetologia; 2002 Jun; 45(6):831-40. PubMed ID: 12107727
[TBL] [Abstract][Full Text] [Related]
57. Simultaneous blockade of co-stimulatory signals, CD28 and ICOS, induced a stable tolerance in rat heart transplantation.
Guo L; Fujino M; Kimura H; Funeshima N; Kitazawa Y; Harihara Y; Tezuka K; Makuuchi M; Suzuki S; Li XK
Transpl Immunol; 2003; 12(1):41-8. PubMed ID: 14551031
[TBL] [Abstract][Full Text] [Related]
58. CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates.
Kirk AD; Harlan DM; Armstrong NN; Davis TA; Dong Y; Gray GS; Hong X; Thomas D; Fechner JH; Knechtle SJ
Proc Natl Acad Sci U S A; 1997 Aug; 94(16):8789-94. PubMed ID: 9238056
[TBL] [Abstract][Full Text] [Related]
59. Suppressive effects of CTLA4-Ig on nasal allergic reactions in presensitized murine model.
Sato J; Asakura K; Murakami M; Uede T; Kataura A
Life Sci; 1999; 64(9):785-95. PubMed ID: 10075111
[TBL] [Abstract][Full Text] [Related]
60. Allochimeric class I MHC protein-induced tolerance by partial TCR engagement requires activation of both CTL4- and common gamma-chain-dependent cytokine signals.
Stepkowski SM; Kirken RA; Trawick BW; Wang M; Tejpal N; Wang ME; Tian L; Clark J; Kahan BD
Transplantation; 2002 Apr; 73(8):1227-35. PubMed ID: 11981413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
